Prosecution Insights
Last updated: August 16, 2026
Application No. 18/316,979

Sulfonium-Salt-Type Polymerizable Monomer, Polymer Photoacid Generator, Base Rein, Resist Composition, And Patterning Process

Final Rejection §103§112
Filed
May 12, 2023
Priority
May 17, 2022 — JP 2022-81150
Examiner
CHACKO DAVIS, DABORAH
Art Unit
1737
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shin-Etsu Chemical Co., Ltd.
OA Round
2 (Final)
72%
Grant Probability
Favorable
3-4
OA Rounds
1m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
710 granted / 988 resolved
+6.9% vs TC avg
Strong +21% interview lift
Without
With
+20.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
35 currently pending
Career history
1023
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
35.9%
-4.1% vs TC avg
§102
28.3%
-11.7% vs TC avg
§112
25.4%
-14.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 988 resolved cases

Office Action

§103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 4 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 4 recites “A-X- being the non-nucleophilic counterion having the polymerizable group represented by at least one of the general formulae (1-A) to (1-C)…...” and is the same non-nucleophilic counterion A-X- of formulae (1-A) to (1-C) in claim 1, and claim 4 does not add a further limitation to the non-nucleophilic counterion that is already fully recited in claim 1. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1, 4-19, is/are rejected under 35 U.S.C. 103 as being unpatentable over U. S. Patent Application Publication No. 2022/0107560 (hereinafter referred to as Fukushima) in view of U. S. Patent Application Publication No. 2021/0188770 (hereinafter referred to as Fujiwara). Fukushima, in the abstract, in [0024]-[0032], and [0036], discloses a resist composition comprising a sulfonium salt as a photoacid generator, the sulfonium salt has the claimed structure, see below, PNG media_image1.png 93 282 media_image1.png Greyscale , wherein the hydrocarbyl group that is bound to the sulfonium ion that comprises the aryl group (disclosed above) includes an acid labile group substitution (claimed [O-RALU]) and includes a fluorinated group as further substitution, see below, PNG media_image2.png 166 152 media_image2.png Greyscale , PNG media_image3.png 147 149 media_image3.png Greyscale , PNG media_image4.png 146 156 media_image4.png Greyscale , PNG media_image5.png 143 147 media_image5.png Greyscale , PNG media_image6.png 152 143 media_image6.png Greyscale , and the R2 is a hydrocarbyl group (claimed R11), and the X- group disclosed above is an anion that includes a polymerizable group (claim 1). Fukushima, in the abstract, in [0024]-[0032], and [0036], discloses a sulfonium salt structure, PNG media_image7.png 104 262 media_image7.png Greyscale , wherein the hydrocarbyl group that is bound to the sulfonium ion that comprises the aryl group (disclosed above) includes an acid labile group substitution (claimed [O-RALU]) and includes a fluorinated group as further substitution. Fukushima, in [0029]-[0033], discloses that the anion (claimed counterion) having the polymerizable group, has the following structure, see below, PNG media_image8.png 108 238 media_image8.png Greyscale , wherein X1, X2, and L4, are each either a single bond or methylene or phenylene or carbonyl or ester group and Q1, Q2, Q3, and Q4, are each fluorine or fluorinated alkyl groups and is the same as the claimed structure recited in claim 4. Fukushima, in [0036]-[0037[, discloses that the resist composition comprises a base polymer (base resin) with repeat units wherein the repeat units include the repeat unit of the photoacid generator comprising the sulfonium salt (i.e., photoacid generator is a copolymer), see below, PNG media_image9.png 254 233 media_image9.png Greyscale (claims 5-6, and 9). Fukushima, in [0035]-[0036], discloses that the resist composition comprising the base polymer includes the following repeat units, see below, PNG media_image10.png 262 138 media_image10.png Greyscale , wherein Y1, and Y2, are the same as the claimed ZA, and ZB, and includes single bond or phenylene or a -C(=O)-O-Y11, wherein the Y11 includes C1-C10 alkanediyl or phenylene or naphthalene group, and is the same claimed repeat units recited (claims 7, and 10). Fukushima, in [0035], and [0038], discloses a resist composition that comprises the base polymer includes further repeats, see below, PNG media_image11.png 117 127 media_image11.png Greyscale , PNG media_image12.png 138 145 media_image12.png Greyscale , wherein Ap is a polar group and is the same as the claimed YA, and is the same as the repeat units recited (claims 8, and 11). Fukushima, in [0120], discloses that the resist composition further comprises another photoacid generator (other than the sulfonium salt pendant repeat unit of the base polymer), a quencher, and a surfactant (that is insoluble or substantially insoluble in water or alkaline developer), and an organic solvent (see [0118]) (claims 12-15). Fukushima, in [0042], discloses that the resist composition is coated on a substrate to form a resist film, exposing a selective region to EB or EUV (high energy rays), developing the exposed resist film (claims 16-17). Fukushima, in [0043], discloses that the developing can be in an alkaline aqueous developer to form a positive pattern (dissolves exposed region away leaving behind the unexposed region to form the pattern) (claim 18). Fukushima, in [0044], discloses that the developing can be in an organic solvent to form the negative pattern (unexposed region of the resist film dissolved away leaving the exposed region to form the pattern) (claim 19). Fukushima, in the abstract, in [0024]-[0032], and [0036], discloses a sulfonium salt structure, PNG media_image7.png 104 262 media_image7.png Greyscale , wherein the hydrocarbyl group that is bound to the sulfonium ion that comprises the aryl group (disclosed above) includes an acid labile group substitution (claimed [O-RALU]) and includes a fluorinated group as further substitution. Fukushima, in [0029]-[0033], discloses that the anion (claimed counterion) having the polymerizable group, has the following structure, see below, PNG media_image8.png 108 238 media_image8.png Greyscale , wherein X1, X2, and L4, are each either a single bond or methylene or phenylene or carbonyl or ester group and Q1, Q2, Q3, and Q4, are each fluorine or fluorinated alkyl groups and is the same as the claimed structure recited in claim 4. The difference between the claims and Fukushima is that Fukushima does not disclose that the acid labile group is the structure recited in claim 2. Fujiwara, in [0059]-[0060], discloses that the acid labile group that substitutes the hydrogen on the aryl group (bonded to the sulfonium cation) can include -O-C(=O)-tBu group. Therefore, it would be obvious to a skilled artisan to modify Fukushima to use the acid labile group taught by Fujiwara, because Fukushima teaches that the substitution in the aryl group is with an acid-labile group and Fujiwara, discloses in [0092] that the acid labile group in combination with onium salt compound results in an improvement in contrast (after developing). Response to Arguments Applicant’s arguments, see Amendment, filed April 9, 2026, with respect to claim 1, have been fully considered and are persuasive. The 35 U.S.C. 102(a)(1) rejection made over claims 1, 3, have been withdrawn. Applicant's arguments filed April 9, 2026, with respect to claims 2, 4, have been fully considered but they are not persuasive. The 35 U.S.C. 103 rejection, made in the previous office action has been maintained. With respect to applicant’s argument that neither Fukushima nor Fujiwara is related to the technical effect that the PAG sulfonium salt has a polymerizable group in the anion portion that can be copolymerized with the base resin so as to inhibit diffusion of the generated acid, Fukushima teaches a base polymer in [0036]-[0039] wherein the base polymer is co-polymerized with the anion portion of the sulfonium salt (PAG), and will inherently inhibit the acid diffusion of the generated acid (photo generated acid by the sulfonium salt). With respect to applicant’s argument that the acid labile group taught by Fujiwara is outside the scope of the specific structure of the claimed ALU-1 or ALU-2, Fukushima teaches in [0036] the claimed sulfonium salt that has the polymerizable anion, and discloses the acid labile group that is bonded to at least one aryl group, however, Fujiwara is dependent upon to disclose the claimed acid labile group and applicant’s acid labile groups recited as ALU-1 and ALU-2 illustrates a structure wherein the (–(C=O)-O-) group can be “0” i.e., u or v can be “0”, i.e., the acid labile group can be structures such as -C-(R1R2R3) wherein C is bonded to the -O- group substituted on the aryl group, and includes structures disclosed on pages 8, 9, of Fujiwara that has the claimed acid labile groups, for instances when v and/or u = 0 in ALU-1 and ALU-2, see below, PNG media_image13.png 265 189 media_image13.png Greyscale , PNG media_image14.png 239 189 media_image14.png Greyscale , PNG media_image15.png 229 351 media_image15.png Greyscale . Therefore, Fujiwara teaches the same claimed acid-labile groups and is within the scope of the specific structure recited, and Fukushima teaches acid labile groups, and discloses a sulfonium salt that has a polymerizable anion group, and Fukushima does not limit the PAG to a monomeric PAG, and therefore, Fukushima in view of Fujiwara discloses the claimed sulfonium salt structure. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Daborah Chacko-Davis whose telephone number is (571) 272-1380. The examiner can normally be reached on 9:30AM-6:00PM EST Mon-Fri. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sally A. Merkling can be reached on (571) 272-6297. The fax phone number for the organization where this application or proceeding is assigned is 571-272-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DABORAH CHACKO-DAVIS/Primary Examiner, Art Unit 1737
Read full office action

Prosecution Timeline

May 12, 2023
Application Filed
Jan 21, 2026
Non-Final Rejection mailed — §103, §112
Apr 09, 2026
Response Filed
Jun 22, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12704785
Point of Use Solvent Mixing for Film Removal
4y 5m to grant Granted Aug 11, 2026
Patent 12703713
TIN COMPOUND AND RESIST SOLUTION USING THE SAME, PATTERN FORMING METHOD, THIN FILM, PATTERNED THIN FILM, AND METHOD FOR PRODUCING TIN COMPOUND
1y 11m to grant Granted Aug 11, 2026
Patent 12693595
ORGANOMETALLIC COMPOUND COMPRISING A METAL COMBINED WITH AT LEAST ONE LIGAND CONTAINING FOUR OR MORE FLUORINE ATOMS, RESIST COMPOSITION COMPRISING THE SAME, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE USING THE SAME
3y 4m to grant Granted Jul 28, 2026
Patent 12681383
LITHOGRAPHY FOCUS CONTROL METHOD
4y 5m to grant Granted Jul 14, 2026
Patent 12681389
EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION
3y 5m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
72%
Grant Probability
93%
With Interview (+20.7%)
3y 4m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 988 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month